|
SURF2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.08626474271523E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.24889995514843E-10 |
| Normal-vs-Stage2 |
3.017100E-04 |
| Normal-vs-Stage3 |
5.17599999527718E-08 |
| Normal-vs-Stage4 |
4.89280000004477E-06 |
| Stage1-vs-Stage2 |
6.549200E-01 |
| Stage1-vs-Stage3 |
5.453600E-01 |
| Stage1-vs-Stage4 |
8.999800E-01 |
| Stage2-vs-Stage3 |
9.964600E-01 |
| Stage2-vs-Stage4 |
6.655200E-01 |
| Stage3-vs-Stage4 |
5.659400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.94579940838003E-11 |
| Normal-vs-AfricanAmerican |
5.195600E-03 |
| Normal-vs-Asian |
1.60900000001352E-06 |
| Caucasian-vs-AfricanAmerican |
6.725000E-01 |
| Caucasian-vs-Asian |
1.134010E-01 |
| AfricanAmerican-vs-Asian |
1.925050E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.75829995008314E-09 |
| Normal-vs-Female |
9.78349623537156E-11 |
| Male-vs-Female |
2.522200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.90490004168009E-09 |
| Normal-vs-Age(41-60Yrs) |
7.12420011872439E-10 |
| Normal-vs-Age(61-80Yrs) |
9.80589999977077E-07 |
| Normal-vs-Age(81-100Yrs) |
3.128200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.362000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.776000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.055400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.377200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.546640E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.220400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.788400E-01 |
| Classical-VS-Follicular |
1.232420E-01 |
| Classical-VS-Other |
1.177220E-01 |
| Classical-VS-Normal |
3.24519966454773E-10 |
| Tall-VS-Follicular |
2.688200E-01 |
| Tall-VS-Other |
1.529610E-01 |
| Tall-VS-Normal |
4.977900E-03 |
| Follicular-VS-Other |
4.568600E-01 |
| Follicular-VS-Normal |
3.92219999811871E-08 |
| Other-VS-Normal |
2.467800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.499778162246E-12 |
| Normal-vs-N1 |
3.98400000000132E-05 |
| N0-vs-N1 |
6.443200E-01 |
|
|
